Tumor treating fields plus temozolomide for newly diagnosed glioblastoma: a sub-group analysis of Korean patients in the EF-14 phase 3 trial
Chae‐Yong Kim, Sun Ha Paek, Do‐Hyun Nam, Jong Hee Chang, Yong-Kil Hong, Jeong Hoon Kim, Oh Lyong Kim, Se-Hyuk Kim
Topics & Concepts
TemozolomideMedicineInternal medicineAdverse effectPopulationCancerProgression-free survivalIncidence (geometry)OncologySurgeryChemotherapyOpticsPhysicsEnvironmental healthGlioma Diagnosis and TreatmentUltrasound and Hyperthermia ApplicationsBrain Metastases and Treatment